Psykey, Inc. (OTCMKTS:CEOS) Short Interest Update

Psykey, Inc. (OTCMKTS:CEOS) was the recipient of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 149,000 shares, a growth of 6,108.3% from the November 15th total of 2,400 shares. Based on an average daily trading volume, of 4,605,200 shares, the short-interest ratio is currently 0.0 days.

Psykey Price Performance

Shares of CEOS opened at $0.03 on Friday. Psykey has a 1-year low of $0.01 and a 1-year high of $0.05. The firm has a fifty day moving average price of $0.02 and a 200 day moving average price of $0.02.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.